Lataa...
What can we learn from drug marketing efficiency?
The time it takes new drugs to penetrate the market is shrinking. David Kao suggests how drug companies’ techniques could be used to improve safety surveillance systems
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group Ltd.
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3230247/ https://ncbi.nlm.nih.gov/pubmed/19050331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.a2591 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|